欢迎访问《中国农学通报》，
中国农学通报

中国农学通报 ›› 2022, Vol. 38 ›› Issue (34): 155-164.doi: 10.11924/j.issn.1000-6850.casb2021-1204

所属专题： 生物技术； 园艺

• 农业信息·科技教育 • 上一篇    

国内外穿心莲研究态势分析

孙铭阳1,2(), 徐世强1,2, 张闻婷1,2, 顾艳1,2, 梅瑜1,2, 李静宇1,2, 周芳1,2, 王继华1,2()   

  1. 1广东省农作物遗传改良重点实验室/广东省农业科学院作物研究所，广州 510640
    2广东省道地南药资源保护与利用工程中心，广州 510640
  • 收稿日期:2021-12-20 修回日期:2022-05-16 出版日期:2022-12-05 发布日期:2022-11-25
  • 通讯作者: 王继华
  • 作者简介:孙铭阳，女，1993年出生，吉林德惠人，助理研究员，博士，主要从事作物遗传育种研究。通信地址：510640 广东省广州市天河区金颖路西二街18号 广东省农科院作物研究所，E-mail：sunmingyangphy@163.com。
  • 基金资助:
    广东省农业科学院作物研究所/广东省农作物遗传改良重点实验室开放研究基金(202101);科技创新战略专项资金（高水平农科院建设）-金颖之星(R2019PY-JX003);广东省重点领域研发计划项目“广藿香等6种岭南中药材新品种培育研究”(2020B020221001);以农产品为单元的广东省现代农业产业技术体系创新团队建设项目（南药产业）(2019KJ148)

Advances in Scientific Research on Andrographis paniculata

SUN Mingyang1,2(), XU Shiqiang1,2, ZHANG Wenting1,2, GU Yan1,2, MEI Yu1,2, LI Jingyu1,2, ZHOU Fang1,2, WANG Jihua1,2()   

  1. 1Guangdong Provincial Key Laboratory of Crops Genetics and Improvement/ Guangdong Academy of Agriculture Sciences, Crop Research Institute, Guangzhou 510640
    2Guangdong Provincial Engineering & Technology Research Center for Conservation and Utilization of the Genuine Southern Medicinal Resources, Guangzhou 510640
  • Received:2021-12-20 Revised:2022-05-16 Online:2022-12-05 Published:2022-11-25
  • Contact: WANG Jihua

RichHTML

4

PDF (PC)

30

摘要：

为了解穿心莲(Andrographis paniculata)的研究现状和学科发展，通过科学网(Web of Science，WoS)核心合集搜索2001—2020年发表的穿心莲SCI学术论文，结合文献计量学描述性和关联性指标，明确穿心莲近20年的科研态势。结果表明：（1）2019—2020年穿心莲的年发文量突破100篇，多数以穿心莲内酯的抑癌功能为核心展开。（2）虽然发文量最多的国家是印度、中国和马来西亚，但中国与美国和澳大利亚的合著关系最近。结合发文量、H指数与论文年均被引数，美国仅凭中国发文量1/5的产出就达到与中国持平的国际影响力，成果受到高度重视，中国穿心莲论文质量仍需提高。（3）印度科学工业研究理事会(CSIR)和新加坡国立大学是被引频次最高的穿心莲科研机构。台湾中华医科大学、中国科学院、上海中医药大学和中山医学大学是中国主要的穿心莲科研机构。（4）穿心莲发文量前3名作者均来自中国。（5）新加坡国立大学Wong W S F团队于2009年发表穿心莲至今为止影响因子最高(21.4)的学术论文，阐明穿心莲内酯缓解哮喘的分子机制。“天然抗生素”穿心莲内酯抑制新型冠状病毒蛋白活性的功能公开引起国际学者的高度重视，关于穿心莲药理药效和高产稳产等基础研究将更加深入。

关键词: 穿心莲, 穿心莲内酯, 科学网, 文献计量, 可视化

Abstract:

This study aims to understand the research status and disciplinary development of Andrographis paniculata (AP). By searching the core collection of Web of Science (WoS) SCI academic papers published from 2001 to 2020, and combining with bibliometrics descriptive and correlation indicators, the research situation of AP in the 20 years was clarified. The results are as follows. (1) In 2019-2020, the annual number of papers published on AP exceeded 100, most of which focused on the anti-cancer function of andrographolide. (2) Although India, China and Malaysia were the countries with the largest number of publications, China had the most recent coauthored relationships with the United States and Australia. Considering the number of papers published, H index and annual citations of papers, the United States achieved international influence equal to that of China with only 1/5 of the published papers of China. The research results of the United States were highly valued, and the quality of Chinese papers still needs to be improved. (3) The most frequently cited research institutions of AP were CSIR and the National University of Singapore. China Medical University in Taiwan, Chinese Academy of Sciences, Shanghai University of Traditional Chinese Medicine and Sun Yat-sen University of Medical Science were the major research institutions of AP in China. (4) The top 3 authors with the largest number of papers were all from China. (5) Wong W S F’s team of the National University of Singapore published an academic paper in 2009 with the highest impact factor (21.4) so far, illustrating the molecular mechanism of andrographolide in relieving asthma. With the disclosure of the function of ‘natural antibiotic’ andrographolide in inhibiting COVID-19 protein activity, international scholars have attached great importance to it, and the basic research on the pharmacological effect and high and stable yield of AP will be further deepened.

Key words: Andrographis paniculata, andrographolide, Web of Science, bibliometrics, visualization

中图分类号: